Global X Launches New Small-Cap and Bitcoin ETFs on Cboe Canada
TORONTO — Today, Cboe Canada Inc. (' Cboe Canada ') is pleased to announce the launch of three new ETFs from Global X Investments Canada Inc. (' Global X '). Now trading on Cboe Canada under the symbols RSCL, BCCC, and BCCL, the new funds offer access to small-cap U.S. equities and bitcoin.
Article content
Article content
'With the launch of Global X Bitcoin Covered Call ETF (BCCC) and Global X Enhanced Bitcoin Covered Call ETF (BCCL), investors now have two ways to gain exposure to the price of Bitcoin, with the benefit of twice monthly distributions – a first in the Canadian marketplace,' said Chris McHaney, Executive Vice President, Investment Management & Strategy at Global X. 'We've seen significant demand for investments that can deliver consistently for Canadians, as well as a continued appetite for cryptocurrency-focused ETFs. With that in mind, we're excited to bring these new ETFs onto Cboe and continue building on our track record of innovation.'
Article content
The new Global X ETFs are as follows:
Article content
Global X Enhanced Russell 2000 Covered Call ETF – ( RSCL) seeks to provide exposure to small-capitalization U.S. equities by tracking the performance of the Russel 2000 RIC Capped Index and seeks to provide high monthly distributions of dividend income and call option premiums. To generate premiums, RSCL engages in a dynamic covered call option writing program.
Article content
Global X Bitcoin Covered Call ETF – ( BCCC) is designed to provide exposure to the performance of bitcoin and distributions of call option premiums. BCCC primarily invests, directly or indirectly, in exchange traded funds that provide exposure to bitcoin. BCCC will also write covered call options on up to 50% of the option eligible securities held in the portfolio of the fund to provide semi-monthly distributions and will not hedge foreign currency exposure.
Article content
Global X Enhanced Bitcoin Covered Call ETF – ( BCCL) is designed to provide exposure to the performance of bitcoin and high distributions of call option premiums. BCCL also employs leverage through cash borrowing and generally endeavours to maintain a leverage ratio of approximately 125%. BCCL anticipates that it will seek to achieve its investment objective by investing in securities of an exchange traded fund. BCCL will employ a dynamic covered call option writing program to generate semi-monthly distributions and mitigate downside risk. BCCL will not hedge its exposure to foreign currencies back to the Canadian dollar.
Article content
'It is our pleasure to welcome Global X back to Cboe Canada for another significant ETF launch,' said Victor Werny, Head of North American ETP Listings at Cboe Global Markets. 'Global X has consistently demonstrated leadership in creating accessible investment vehicles for sophisticated strategies and we look forward to strengthening our collaboration across Cboe's global footprint as they continue to bring new investment solutions to market.'
Article content
The new funds are now trading alongside 13 Global X ETFs already listed on Cboe Canada. Investors can trade units of all Global X ETFs through their usual investment channels, including discount brokerage platforms and full-service dealers.
Article content
Cboe Canada is home to ETFs from Canada's largest ETF issuers, over 100 Canadian Depositary Receipts (CDRs), and some of the most innovative Canadian and international growth companies. Cboe consistently facilitates 15% of all volume traded in Canadian listed securities. Click here for a complete view of all Cboe-listed securities in Canada.
Article content
Cboe Canada is a Tier 1 stock exchange providing a best-in-class listing experience for issuers that are shaping the economies of tomorrow. Fully operational since 2015, Cboe Canada lists investment products and companies seeking an internationally recognized stock exchange that enables investor trust, quality liquidity, and broad awareness including unfettered access to market data.
Article content
Cboe Canada is part of Cboe Global Markets, the leading securities and derivatives exchange network. With exchanges in North America, Europe, and Asia Pacific, Cboe is harnessing its footprint around the world to equip Issuers with essential capital market solutions.
Article content
Cboe powers ETF Market Canada, a user-friendly platform providing investors and advisors with one-stop access to ETF research and analysis. Real-time, institutional-grade data allows users to compare, contrast, and explore the entire universe of 1,200+ Canadian ETFs, free of charge.
Article content
Global X Investments Canada Inc. ('Global X') is an innovative financial services company and offers one of the largest suites of exchange traded funds in Canada. The Global X product family includes a broadly diversified range of solutions for investors of all experience levels to meet their investment objectives in a variety of market conditions. Global X has approximately $38 billion of assets under management and 142 ETFs listed on major Canadian stock exchanges. Global X is a wholly owned subsidiary of the Mirae Asset Financial Group, which manages approximately $900 billion of assets across 19 countries and global markets around the world.
Article content
Article content
Article content
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Toronto Star
3 days ago
- Toronto Star
Abaxx Provides Q2 2025 Corporate Update
TORONTO, Aug. 15, 2025 (GLOBE NEWSWIRE) — Abaxx Technologies Inc. (CBOE:ABXX)(OTCQX:ABXXF) ('Abaxx' or the 'Company'), a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte Ltd., the owner of Abaxx Commodity Exchange and Clearinghouse (individually, 'Abaxx Exchange' and 'Abaxx Clearing'), and producer of the SmarterMarkets™ Podcast, provides an update on operational milestones and the continued execution of the Company's business strategy in the second quarter of 2025. Since quarter-end, the Company has entered a transformational period, with key developments from July and August outlined in the highlights below. On August 11, 2025, Abaxx CEO and Founder Josh Crumb hosted a Special Mid-Year Investor Update Call to update shareholders on these transformational events and the current state of the Company. A recording of this presentation is available on the Abaxx Investor Relations website at
Cision Canada
3 days ago
- Cision Canada
Light AI reports Financial Results for Three and Six Months ended June 30, 2025
VANCOUVER, BC, /CNW/ - Light AI Inc. (" Light AI" or the " Company") (CBOE: CA) (CBOE: ALGO) (FSE: 0HC) (OTCQB: OHCFF), a healthcare technology company focused on developing artificial intelligence ("AI") health diagnostic and wellness solutions, today announced its financial and operating results for its second quarter of 2025 representing the three and six months ended June 30, 2025. Financial information is reported in Canadian dollars ("$") unless otherwise stated and in accordance with International Financial Reporting Standards ("IFRS"). Financial and Operating Results Summary for the three and six months ended June 30, 2025 The Company is currently in the development stage of its software technology offering anticipated to be completed with related commercialization commencing in late 2025. During the three months ended June 30, 2025, the Company had total operating expenses, exclusive of interest, depreciation and share based payments, of $4.0 million compared to $4.2 million for the three months ended March 31, 2025 and $2.0 million for the three months ended June 30, 2025. The change is primarily attributable to the Company's incremental investment in its product development with total research and development expenses of $1.4 million in Q2 2025 compared to $1.2 million for the three months ended March 31, 2025 and $1.1 million in the prior year period in addition to marketing and investor relations activities of approximately $2.1 million in Q2 2025 compared to $2.4 million for the three months ended March 31, 2025 and $0.3 million in the prior year period. The Company had total operating expenses of $8.3 million for the six months ended June 30, 2025 which increased from $3.8 million in the prior year period due primarily to marketing and investor relations expenses in addition to increased product development costs. The Company had cash of $9.4 million with total assets of $10.8 million as at June 30, 2025 compared to cash of $15.2 million with total assets of $17.1 million as at December 31, 2024. On January 8, 2025, the Company closed the second of two tranches of the Offering by issuing 2,757,000 units of the Company at $0.55 per unit for aggregate gross proceeds of $1,516,350. The Company had Adjusted Working Capital of $8.9 million as at June 30, 2025 compared to $14.6 million as at December 31, 2024. "Light AI continues to make progress towards commercializing its AI oriented wellness software application anticipated to be commercially available after Q3 2025," stated Peter Whitehead, CEO. "We are well positioned to capitalize on our sizable market opportunity leveraging Light AI's first mover advantage with our patented intellectual property and technology." Financial Statements and Management Discussion & Analysis Please see the Company's consolidated financial statements ("Financial Statements") and related Management's Discussion & Analysis ("MD&A") for more details. The Financial Statements for the three and six months ended June 30, 2025, and related MD&A have been reviewed and approved by the Company's Audit Committee and Board of Directors. For a more detailed explanation and analysis, please refer to the MD&A that has been filed on SEDAR+ at and is also available on the Company's website at Non-IFRS and Other Financial Measures This press release refers to the following non-IFRS measures: "Adjusted Working Capital" is comprised as current assets less current liabilities. Management believes Adjusted Working Capital is a useful indicator for investors, and is used by management, for evaluating the operating liquidity to the Company. See "Adjusted Working Capital Reconciliation" for a quantitative reconciliation of Adjusted Working Capital to the most directly comparable financial measure. Such non-IFRS measures and non-IFRS ratio do not have a standardized meaning under IFRS and may not be comparable to a similar measure disclosed by other issuers. About Light AI Inc. (CBOE CA: ALGO / FSE: 0HC / OTCQB: OHCFF) Light AI Inc. is a technology company focused on developing artificial intelligence health screening and diagnostic solutions. Light AI is developing a technology platform which represents the next generation of patient management: it applies AI algorithms to smartphone images—starting with images of Strep A and anticipated expansion with COVID19 along with other medical conditions —to identify the disease in seconds. Its patented, app-based solution requires no swabs, lab tests or proprietary hardware of any kind—its hardware platform is the 4.5 billion smartphones that exist in the world today. Light AI is at the forefront of developing innovative screening and diagnostic solutions aimed at improving healthcare delivery worldwide. Their cutting-edge AI powered technology offers rapid, accurate, and cost-effective screening and diagnostic tools designed to address critical healthcare challenges. In pre-FDA validation studies, Light AI's algorithm demonstrated remarkable accuracy in differentiating between viral and bacterial pharyngitis, specifically targeting Group A Streptococcus (GAS). The algorithm achieved a 96.57% accuracy rate and attained a Negative Predictive Value of 100%, indicating its high reliability in confirming the absence of Streptococcus A infection. Viral and GAS pharyngitis affects over 600 million people annually worldwide. If left untreated, GAS pharyngitis can lead to serious complications such as Rheumatic Heart Disease (RHD), which imposes a global economic burden exceeding $1 trillion annually. Light AI's technology offers a significant advancement in the accurate and timely identification of GAS pharyngitis, potentially reducing the incidence of RHD and its associated costs. Light AI's approach to applying AI to smartphone images can be expanded to other throat conditions, as well as other areas of analysis, such as the human eye and skin. Light AI's vision is to combine the smartphone with AI in-the-Cloud to create a Digital Clinical Lab that provides quick and accessible diagnosis for countless conditions that today require expensive and time-consuming imaging or lab processes. Light AI's commercial launch of its consumer-facing Wellness App initial offering is anticipated to be available in North America in Q3 2025. ON BEHALF OF THE COMPANY "George Reznik" George Reznik Chief Financial Officer Telephone: 604-307-6800 Email: [email protected] For more information, please contact the Company at [email protected] or visit Forward-Looking Information: This news release includes information, statements, beliefs and opinions which are forward-looking, and which reflect current estimates, expectations and projections about future events, including, but not limited to, the Company's research and development and commercialization initiatives, the anticipated inflection of the business, the Company's financial and operational performance and outlook and other statements that contain words such as "believe," "expect," "project," "should," "seek," "anticipate," "will," "intend," "positioned," "risk," "plan," "may," "estimate" or, in each case, their negative and words of similar meaning. By its nature, forward-looking information involves a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking information. These risks, uncertainties and assumptions could adversely affect the outcome of the plans and events described herein. Readers should not place undue reliance on forward-looking information, which is based on the information available as of the date of this news release. For a list of the factors that may affect any of the Company's forward-looking statements, please refer to the Company's annual information form dated April 14, 2025 and other filings made by the Company with the Canadian securities regulatory authorities (which may be viewed under its SEDAR+ profile at
Toronto Star
3 days ago
- Toronto Star
VERSES Announces Filing of Quarterly Report on Form 10-Q
VANCOUVER, British Columbia, Aug. 14, 2025 (GLOBE NEWSWIRE) — VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSF) ('VERSES' or the 'Company'), a cognitive computing company pioneering next-generation agentic software systems today announced that it has filed its Quarterly Report on Form 10-Q ('Quarterly Report') for the three months ended June 30, 2025, with the U.S. Securities and Exchange Commission ('SEC'). 'We are pleased to report our results for the three months ending June 30, 2025 in our Quarterly Report on Form 10-Q. I believe these results demonstrate disciplined cost management, even as Verses begins to scale and commercialize, market and sell its flagship product Genius. The results also highlight the first revenue generated by Genius after only two months following its launch. I believe that these results underscore our prudent approach to managing cash as well as the strong customer interest we've anticipated from the outset. We are all energized by this momentum as we head into the remainder of the year,' said James Christodoulou, CFO of VERSES.
